Empowering Cancer Immunotherapy with Artificial Intelligence

Innovative software solutions to guide the discovery of neoantigen-based personalized immunotherapies and biomarkers.

Artificial Intelligence
Artificial Intelligence
Proprietary machine learning algorithms and data to predict antigen presentation and immunogenicity
+
Immunotherapy
Immunotherapy
Applied to the selection of patient specific targets in immuno-oncology clinical trials
=
Personalized<br/>Cancer Medicine
Personalized
Cancer Medicine
Truly personalized and novel cancer immunotherapies to empower your neoantigen clinical trial success